These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 28903417)
1. Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1. Yang L; Ritchie AM; Melton DW Oncotarget; 2017 Aug; 8(33):55246-55264. PubMed ID: 28903417 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance. McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741 [TBL] [Abstract][Full Text] [Related]
3. The structure of the human ERCC1/XPF interaction domains reveals a complementary role for the two proteins in nucleotide excision repair. Tripsianes K; Folkers G; Ab E; Das D; Odijk H; Jaspers NG; Hoeijmakers JH; Kaptein R; Boelens R Structure; 2005 Dec; 13(12):1849-58. PubMed ID: 16338413 [TBL] [Abstract][Full Text] [Related]
4. The HhH domain of the human DNA repair protein XPF forms stable homodimers. Das D; Tripsianes K; Jaspers NG; Hoeijmakers JH; Kaptein R; Boelens R; Folkers GE Proteins; 2008 Mar; 70(4):1551-63. PubMed ID: 17912758 [TBL] [Abstract][Full Text] [Related]
5. Computational Characterization of Small Molecules Binding to the Human XPF Active Site and Virtual Screening to Identify Potential New DNA Repair Inhibitors Targeting the ERCC1-XPF Endonuclease. Gentile F; Barakat KH; Tuszynski JA Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29710850 [TBL] [Abstract][Full Text] [Related]
6. Single-stranded DNA Binding by the Helix-Hairpin-Helix Domain of XPF Protein Contributes to the Substrate Specificity of the ERCC1-XPF Protein Complex. Das D; Faridounnia M; Kovacic L; Kaptein R; Boelens R; Folkers GE J Biol Chem; 2017 Feb; 292(7):2842-2853. PubMed ID: 28028171 [TBL] [Abstract][Full Text] [Related]
7. Domain mapping of the DNA binding, endonuclease, and ERCC1 binding properties of the human DNA repair protein XPF. McCutchen-Maloney SL; Giannecchini CA; Hwang MH; Thelen MP Biochemistry; 1999 Jul; 38(29):9417-25. PubMed ID: 10413517 [TBL] [Abstract][Full Text] [Related]
8. Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Bhagwat NR; Roginskaya VY; Acquafondata MB; Dhir R; Wood RD; Niedernhofer LJ Cancer Res; 2009 Sep; 69(17):6831-8. PubMed ID: 19723666 [TBL] [Abstract][Full Text] [Related]
9. Computer-aided drug design of small molecule inhibitors of the ERCC1-XPF protein-protein interaction. Gentile F; Elmenoufy AH; Ciniero G; Jay D; Karimi-Busheri F; Barakat KH; Weinfeld M; West FG; Tuszynski JA Chem Biol Drug Des; 2020 Apr; 95(4):460-471. PubMed ID: 31891209 [TBL] [Abstract][Full Text] [Related]
10. The ERCC1 and ERCC4 (XPF) genes and gene products. Manandhar M; Boulware KS; Wood RD Gene; 2015 Sep; 569(2):153-61. PubMed ID: 26074087 [TBL] [Abstract][Full Text] [Related]
11. DCAF7 is required for maintaining the cellular levels of ERCC1-XPF and nucleotide excision repair. Kawara H; Akahori R; Wakasugi M; Sancar A; Matsunaga T Biochem Biophys Res Commun; 2019 Oct; 519(1):204-210. PubMed ID: 31493872 [TBL] [Abstract][Full Text] [Related]
12. Mapping of the regions implicated in nuclear localization of multi-functional DNA repair endonuclease XPF-ERCC1. Akahori R; Takamori C; Wakasugi M; Matsunaga T Genes Cells; 2022 May; 27(5):356-367. PubMed ID: 35238109 [TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells. Arora S; Heyza J; Zhang H; Kalman-Maltese V; Tillison K; Floyd AM; Chalfin EM; Bepler G; Patrick SM Oncotarget; 2016 Nov; 7(46):75104-75117. PubMed ID: 27650543 [TBL] [Abstract][Full Text] [Related]
14. Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts. Guffanti F; Alvisi MF; Caiola E; Ricci F; De Maglie M; Soldati S; Ganzinelli M; Decio A; Giavazzi R; Rulli E; Damia G Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847049 [TBL] [Abstract][Full Text] [Related]
15. Modulation of ERCC1-XPF Heterodimerization Inhibition Weilbeer C; Jay D; Donnelly JC; Gentile F; Karimi-Busheri F; Yang X; Mani RS; Yu Y; Elmenoufy AH; Barakat KH; Tuszynski JA; Weinfeld M; West FG Front Oncol; 2022; 12():819172. PubMed ID: 35372043 [TBL] [Abstract][Full Text] [Related]
16. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs. Kirschner K; Melton DW Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091 [TBL] [Abstract][Full Text] [Related]
17. Recruitment and positioning determine the specific role of the XPF-ERCC1 endonuclease in interstrand crosslink repair. Klein Douwel D; Hoogenboom WS; Boonen RA; Knipscheer P EMBO J; 2017 Jul; 36(14):2034-2046. PubMed ID: 28292785 [TBL] [Abstract][Full Text] [Related]
18. The structure of the XPF-ssDNA complex underscores the distinct roles of the XPF and ERCC1 helix- hairpin-helix domains in ss/ds DNA recognition. Das D; Folkers GE; van Dijk M; Jaspers NG; Hoeijmakers JH; Kaptein R; Boelens R Structure; 2012 Apr; 20(4):667-75. PubMed ID: 22483113 [TBL] [Abstract][Full Text] [Related]
19. XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening. Wu Y; Zacal NJ; Rainbow AJ; Zhu XD DNA Repair (Amst); 2007 Feb; 6(2):157-66. PubMed ID: 17055345 [TBL] [Abstract][Full Text] [Related]
20. The knock-down of ERCC1 but not of XPF causes multinucleation. Rageul J; Frëmin C; Ezan F; Baffet G; Langouët S DNA Repair (Amst); 2011 Sep; 10(9):978-90. PubMed ID: 21839691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]